We use cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details, including how you can amend your preferences, please read our Privacy Policy.
Clinical papers
At ResMed, we’re focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.
We believe that industry and medical science need to work together to enhance medicine and patient therapy.
Consult our numerous research and clinical papers below.
Sleep
ResMed is a global pioneer and leader in sleep and respiratory disorders. All about our research on sleep-disordered breathing and related innovation and technology.
Sleep disordered breathing and mandibular repositioning devices
There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating osbstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.
Cardiology
ResMed is committed to researching the association between sleep apnoea and cardiovascular issues. All about our research on sleep and cardiology, specifically on heart failure and CSA-CSR.
Respiratory care
At ResMed, we provide a number of solutions to treat respiratory disorders. Noninvasive ventilation (NIV) can used to treat patients with respiratory dysfunction. All about respiratory care and NIV.
iVAPS algorithms
At ResMed, we’re focused on improving patient compliance. That’s why we continue to develop ventilators around iVAPS algorithms, an innovative technology that adapts to patients.
Farrell historical landmarks
ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.
Sleep apnoea and digital connected health
Recent research findings show the positive effects of connected health on the treatment of sleep apnoea patients.
iVAPS vs. standard NIV
Randomised trial of 'intelligent' autotitrating ventilation versus standard pressure support non-invasive ventilation: Impact on adherence and physiological outcomes.
Benefits of noninvasive ventilation for COPD in the hospital and home
NIV helps patients with COPD and hypercapnia in hospital and at home.
Recurrent acidotic exacerbations of COPD
Patients with chronic obstructive pulmonary disease (COPD) tend to have frequent exacerbations necessitating hospital admission.
Comparison of S/T mode with iVAPS mode for a COPD patient
Case study of an elderly COPD patient who was switched from ST mode to iVAPS
Improving survival in COPD using NPPV
A prospective, randomised, controlled trial of NPPV in severe stable COPD.
Home ventilation lowers risks in COPD
Lowering the risk of acidotic respiratory failure with non-invasive ventilation at home.
Identifying COPD exacerbations early
Monitoring respiratory frequency at home can facilitate early intervention for COPD patients experiencing exacerbations.
NIV Initiation Protocol
How to initiate NIV in patients with chronic respiratory insufficiency or failure.